Alk5 inhibition increases delivery of macromolecular and protein-bound contrast agents to tumors
Limited transendothelial permeability across tumor microvessels represents a significant bottleneck in the development of tumor-specific diagnostic agents and theranostic drugs. Here, we show an approach to increase transendothelial permeability of macromolecular and nanoparticle-based contrast agen...
Saved in:
Published in | JCI insight Vol. 1; no. 6 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Clinical Investigation
05.05.2016
|
Online Access | Get full text |
ISSN | 2379-3708 2379-3708 |
DOI | 10.1172/jci.insight.85608 |
Cover
Loading…